SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-025185
Filing Date
2021-05-07
Accepted
2021-05-07 17:11:15
Documents
2
Period of Report
2021-05-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea140402-8k_180life.htm 8-K 22296
2 SETTLEMENT AND MUTUAL RELEASE AGREEMENT DATED MAY 4, 2021, BY AND BETWEEN 180 LI ea140402ex10-1_180life.htm EX-10.1 64347
  Complete submission text file 0001213900-21-025185.txt   87903
Mailing Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025
Business Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

IRS No.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38105 | Film No.: 21903935
SIC: 2834 Pharmaceutical Preparations